FUS and myxoid liposarcoma: FUS-CHOP drives tumorigenesis in myxoid liposarcoma by interfering with the expression of transcription factors (including PPARΥ1, PPARΥ2, C/EBPα, C/EBPβ, and C/EBPδ) that regulate the differentiation of adipocyte precursor cells.